- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05218031
Acceptance and Commitment Group Therapy for Unaccompanied Minors
January 19, 2022 updated by: Maria Karekla, University of Cyprus
Acceptance and Commitment Group Therapy for Unaccompanied Minors: A Pilot Study
Unaccompanied minors (UM) are considered to be a highly vulnerable refugee subgroup.
Research has indicated that UM experience traumatic events and consequently develop high levels of psychopathology.
Post-traumatic stress disorder is the most prevalent diagnosis, followed by depression, anxiety disorders as well as traumatic grief and conduct problems.
Acceptance and Commitment Therapy (ACT) may be particularly suited to the treatment of survivors of trauma and with vulnerable refugee groups such as UM.
A 5-week ACT group intervention will be carried out and its feasibility in UM will be explored along with its effect on mental health.
The ACT group intervention will be based on a Self-Help Booklet by the World Health Organization "Doing What Matters in Times of Stress: An Illustrated Guide".
Following the 5-week ACT group intervention, focus groups with participants will be carried out to examine its acceptability and will be analysed qualitatively, using thematic analysis.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
The hypotheses of the study are as follows:
- The ACT group intervention will lead to increases in UM psychological well-being and quality of life compared to a waiting-list (WL) control group. This includes improvements in post-traumatic stress symptoms, depression, anxiety, stress, and sleep difficulties. (Primary outcomes).
- The UM receiving the ACT group intervention will demonstrate improvements in their prosocial behaviour compared to the WL control group. (Primary outcomes).
- At post-intervention, UM receiving the ACT group intervention will have enhanced psychological flexibility compared to the WL control group. It is predicted that there will be decreased experiential avoidance and cognitive fusion, coupled with increases in values-driven committed action, present moment awareness and self-as-context. (Secondary outcomes).
- At the 1-month and 3-month follow-up time points, the UM receiving the ACT group intervention will have retained the improvements from the treatment (i.e., increased psychological wellbeing, enhanced psychological flexibility, augmented prosocial behaviour) compared to the WL control group. Additionally, it is predicted that UM who completed the ACT group intervention will not only have sustained the benefits observed directly post-intervention but will in fact keep making progress at follow-up time points compared to the WL control group.
From the qualitative analysis, the investigators presume to provide critical insights as to what is perceived acceptable and culturally appropriate treatment for this population.
Study Type
Interventional
Enrollment (Anticipated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dafne Morroni, MSc
- Phone Number: 0035799798913
- Email: dmorro01@ucy.ac.cy
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Unaccompanied refugee minors living in sheltered accommodation in Cyprus.
- No specific diagnosis required to take part in the study.
- No specific cultural background required.
- Minors who provide consent.
Exclusion Criteria:
- Presence of active psychosis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ACT Intervention
5-week ACT Group Intervention based on the Self-Help Booklet by the World Health Organization "Doing What Matters in Times of Stress: An Illustrated Guide".
|
A 90-120 minute 5-week group intervention for unaccompanied minors.
Each week there will be a different focus.
Week 1: Grounding, Week 2: Unhooking, Week 3: Values, Week 4: Self-compassion, Week 5: Making room for unwanted thoughts and feelings.
|
No Intervention: Control group
Waiting-list
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in 'Quality of Life': KIDSCREEN-27 (Ravens-Sieberer et al., 2007).
Time Frame: Pre-intervention, Post-intervention (at 5 weeks), 1-month follow-up, 3-months follow-up
|
This is a 27-item instrument that consists of five dimensions of quality of life: physical well-being (5 items), psychological well-being (7 items), autonomy and relationship with parents (7 items), peers and social support (4 items), and school environment (4 items).
The questions concern the last seven days and answers are given on a five-point Likert scale ('Not at all, slightly, moderately, very, extremely' or 'never, seldom, quite often, very often, always').
Higher scores on the KIDSCREEN-27 reflect higher quality of life and wellbeing.
Internal consistency of this scale was considered satisfactory (Cronbach's alpha= >.70).
|
Pre-intervention, Post-intervention (at 5 weeks), 1-month follow-up, 3-months follow-up
|
Change in 'The Depression, Anxiety and Stress Scale' (DASS-21; Lovibond & Lovibond, 1995; Antony, Bieling, Cox, Enns, & Swinson., 1998).
Time Frame: Pre-intervention, Post-intervention (at 5 weeks), 1-month follow-up, 3-months follow-up
|
This scale includes 21 items and will be used to assess for symptoms of depression, anxiety and stress in our sample.
The Depression scale assesses hopelessness, low self-esteem, and low positive affect.
The Anxiety scale assesses autonomic arousal, physiological hyperarousal, and the subjective feeling of fear.
The Stress scale items assess tension, agitation, and negative affect.
There are seven items per scale and participants must rate their past week on a Likert-type scale (0-3).
Higher scores indicate higher levels of depression, stress and anxiety.
Cronbach's alphas indicating high internal consistency for Depression .94,
Anxiety .84 and Stress .91.
|
Pre-intervention, Post-intervention (at 5 weeks), 1-month follow-up, 3-months follow-up
|
Change in 'The Child Revised Impact of Events Scale' (CRIES-8; Perrin, Meiser-Stedman, & Smith., 2005).
Time Frame: Pre-intervention, Post-intervention (at 5 weeks), 1-month follow-up, 3-months follow-up
|
This scale will be used to assess for any post-traumatic stress symptoms.
The total number of items in the scale are 8 items.
Four of the items assess intrusion (intrusive thoughts, feelings) and the remaining four items assess avoidance (avoidance of situations, feelings).
The items are scored on a 4- point scale, where higher scores indicate higher levels of intrusion or avoidance.
The CRIES-13 (Smith, Perrin, Dyregov, & Yule, 2003) was found to have high internal consistency (Cronbach's alpha= 0.80).
Sensitivity (i.e., the probability that someone with a diagnosis of PTSD will screen positive) was found to be .94-1.0.
Specificity (i.e., the probability that someone without a diagnosis of PTSD will screen negative) was found to be .59-.71.
The overall efficiency rate of the CRIES-8 is 75-82.7%.
|
Pre-intervention, Post-intervention (at 5 weeks), 1-month follow-up, 3-months follow-up
|
Change in 'Strengths and Difficulties Questionnaire' (SDQ; Goodman, 1997; 2001).
Time Frame: Pre-intervention, Post-intervention (at 5 weeks), 1-month follow-up, 3-months follow-up
|
This questionnaire consists of 25 items divided into five subscales with 5 items each: Emotional difficulties, Conduct problems, Hyperactivity/inattention, Peer problems and Prosocial behaviour.
Each item is scored on a 3-point scale (0= 'not true', 1='somewhat true', and 2= 'certainly true').
Subscale scores are calculated by summing scores on relevant items (after recoding reversed items).
Higher scores on the prosocial behaviour subscale indicate strengths, whilst higher scores on the other four subscales indicate difficulties.
A total difficulties score is computed by summing the scores on all five subscales (range 0-40).
Reliability of this scale is satisfactory as assessed by internal consistency (Cronbach's alpha=0.73),
cross-informant correlation (mean= 0.34), and retest stability after 4 to 6 months (mean= 0.62).
|
Pre-intervention, Post-intervention (at 5 weeks), 1-month follow-up, 3-months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the ACT Process Measure: PsyFlex (Gloster et al., 2021).
Time Frame: Pre-intervention, throughout study completion 5 weeks, 1-month follow-up, 3-months follow-up
|
This is an 8-item self-report questionnaire which assesses the process of psychological flexibility.
Each item is rated on a five-point scale from 1 (very often) to 5 (very rarely).
|
Pre-intervention, throughout study completion 5 weeks, 1-month follow-up, 3-months follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment Adherence Measure: ACT Fidelity Measure (ACT-FM; O'Neill et al., 2019).
Time Frame: up to 5 weeks
|
This questionnaire consists of 25 items which capture four key areas within ACT: Therapist Stance (7 items), Open Response Style (6 items), Aware Response Style (6 items) and Engaged Response Style (6 items).
Within each area there are items to score the therapist's behaviour as ACT consistent and ACT inconsistent.
Scoring is rated on a 4-point scale from 0-3 (0= 'This behaviour never occurred', 1= 'Therapist rarely enacts this behaviour', 2= 'Therapist sometimes enacts this behaviour', 3= 'Therapist consistently enacts this behaviour').
Within 'Engaged response style' for instance, "Therapist gives the client opportunities to clarify their own values" would be considered ACT consistent, "Therapist imposes their own, other's or society's values upon the client" would be considered ACT inconsistent.
A total score can be calculated for each subscale as well as a total ACT consistent score and total ACT inconsistent score.
Inter-rater reliability was deemed moderate to excellent.
|
up to 5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maria Karekla, Ph.D., University of Cyprus
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2022
Primary Completion (Anticipated)
June 30, 2022
Study Completion (Anticipated)
December 30, 2022
Study Registration Dates
First Submitted
December 10, 2021
First Submitted That Met QC Criteria
January 19, 2022
First Posted (Actual)
February 1, 2022
Study Record Updates
Last Update Posted (Actual)
February 1, 2022
Last Update Submitted That Met QC Criteria
January 19, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- K3_K1_1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Acceptance and Commitment Therapy
-
Francisco Garcia TorresUniversidad de CórdobaRecruiting
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
University of CoimbraUnknown
-
Universiti Sains MalaysiaRecruitingBreast Cancer FemaleMalaysia
-
University of Alabama at BirminghamWithdrawn
-
Nova Scotia Health AuthorityCompleted
-
University of TromsoThe Royal Norwegian Ministry of HealthActive, not recruiting
-
VA Office of Research and DevelopmentCompletedChronic Pain | Mild Traumatic Brain Injury | Distress-based PsychopathologyUnited States
-
University of Alabama at BirminghamCompletedPsychological DistressUnited States
-
Akdeniz UniversityCompletedStress | Caregiver Burden | Anxiety Depression | Acceptance and Commitment Therapy | Caregiver Burnout | Public Health Nurse | Special Needs ChildrenTurkey